India's Glenmark Pharmaceuticals said on Thursday its innovation arm, Ichnos Glenmark Innovation (IGI), and AbbVie have ...

Merck said it will buy Verona Pharma for $10 billion to bolster its lung-disease business and help replace the expected loss ...

Lawmakers bet millions on pharma stocks as Trump targets industry Drug company shares are down amid President Donald Trump’s assault on the industry, but some in Congress see value.

Italy's troubled luxury lingerie company La Perla will be rescued and taken over by Peter Kern, the former chief executive of U.S. travel technology company Expedia, the Italian government said on ...

Astell & Kern's new Luna IEMs feature a newly-developed micro planar magnetic driver for "exceptional" resolution. Available now, they're priced at £2,699 / $2,700 / €3,049 (about AU$5,612).

Story Continues Management Comments Iris Bincovich, CEO of Innocan Pharma, commented: "We are very pleased with our strong start to 2025, marked by solid results in the first quarter.

Astell&Kern has a new Hi-Res Audio player that will debut at High End Munich in May. The SP4000 will go on sale this summer and sports a quad-DAC architecture, new high drive mode, and a host of ...

Kern's portal entry isn't the most surprising development, as the Longhorns turned to the winter portal window to land Utah punter transfer Jack Bouwmeester, who was ranked as the No. 1 punter in ...

Once all-powerful, pharma’s allies in Washington are fleeting The industry is struggling to find its voice as Trump and RFK Jr. rage against it.

Global drugmakers’ stocks dropped across the board today after U.S. President Donald Trump reiterated plans for a “major” tariff on pharmaceutical imports, threatening an interwoven supply ...

A California man was sentenced last week to 25 years in jail after swindling investors out of nearly $18 million in an elaborate CBD scam that involved a fake Kern County hemp farm and cannabis ...

Common Side Effects, Adult Swim's latest animated series, is a conspiracy thriller that takes a much-deserved sledgehammer to Big Pharma.